Matches in Wikidata for { <http://www.wikidata.org/entity/Q65384982> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q65384982 description "clinical trial" @default.
- Q65384982 description "ensayu clínicu" @default.
- Q65384982 description "klinisch onderzoek" @default.
- Q65384982 description "клінічне випробування" @default.
- Q65384982 name "E7389 Administered as an IV Bolus Infusion Day 1 and Day 8 Every 3 Weeks in Pre-Treated Patients With Advanced and/or Metastatic Soft Tissue Sarcoma" @default.
- Q65384982 name "E7389 Administered as an IV Bolus Infusion Day 1 and Day 8 Every 3 Weeks in Pre-Treated Patients With Advanced and/or Metastatic Soft Tissue Sarcoma" @default.
- Q65384982 type Item @default.
- Q65384982 label "E7389 Administered as an IV Bolus Infusion Day 1 and Day 8 Every 3 Weeks in Pre-Treated Patients With Advanced and/or Metastatic Soft Tissue Sarcoma" @default.
- Q65384982 label "E7389 Administered as an IV Bolus Infusion Day 1 and Day 8 Every 3 Weeks in Pre-Treated Patients With Advanced and/or Metastatic Soft Tissue Sarcoma" @default.
- Q65384982 prefLabel "E7389 Administered as an IV Bolus Infusion Day 1 and Day 8 Every 3 Weeks in Pre-Treated Patients With Advanced and/or Metastatic Soft Tissue Sarcoma" @default.
- Q65384982 prefLabel "E7389 Administered as an IV Bolus Infusion Day 1 and Day 8 Every 3 Weeks in Pre-Treated Patients With Advanced and/or Metastatic Soft Tissue Sarcoma" @default.
- Q65384982 P1050 Q65384982-563567C5-A703-47B2-9306-16AEB420BDCE @default.
- Q65384982 P1132 Q65384982-C71A979F-4DDB-43A5-A3C9-F0FFB5D224F3 @default.
- Q65384982 P1476 Q65384982-9BD68316-104F-4F7E-8FBF-72E7B6B26A6F @default.
- Q65384982 P17 Q65384982-278A7B6D-A054-465F-8B3A-BB6567232CEB @default.
- Q65384982 P17 Q65384982-98245D24-2253-45FB-BDDF-E9BBEB9EFFD5 @default.
- Q65384982 P17 Q65384982-B074C7FB-B963-4B81-9ACC-41A53AE6FF86 @default.
- Q65384982 P17 Q65384982-B1581427-0D04-49FD-847E-D5772677C514 @default.
- Q65384982 P17 Q65384982-C454D656-9374-4281-8BC0-0CB7F209FB44 @default.
- Q65384982 P2899 Q65384982-4BE7BF6C-B416-4B6F-8609-E49B0A5C006D @default.
- Q65384982 P3098 Q65384982-69416448-C382-47FB-8283-0774BD88780D @default.
- Q65384982 P31 Q65384982-F7697C85-7B36-456C-A924-2E3771D73D29 @default.
- Q65384982 P580 Q65384982-10478D9A-4299-45D1-B553-829C2ABF25BD @default.
- Q65384982 P582 Q65384982-BDB0E3E1-0176-46B7-A88B-5710D4CE5870 @default.
- Q65384982 P6099 Q65384982-5B8703D5-219D-4383-864D-3BA9C05ECA7D @default.
- Q65384982 P8363 Q65384982-88D0DF7C-493F-474E-B798-1421FAB4ABFD @default.
- Q65384982 P1050 Q223911 @default.
- Q65384982 P1132 "+128" @default.
- Q65384982 P1476 "Phase II Study of E7389 Administered as an IV Bolus Infusion Day 1 and Day 8 Every 3 Weeks in Pre-Treated Patients With Advanced and/or Metastatic Soft Tissue Sarcoma" @default.
- Q65384982 P17 Q142 @default.
- Q65384982 P17 Q183 @default.
- Q65384982 P17 Q31 @default.
- Q65384982 P17 Q35 @default.
- Q65384982 P17 Q36 @default.
- Q65384982 P2899 "+18" @default.
- Q65384982 P3098 "NCT00413192" @default.
- Q65384982 P31 Q30612 @default.
- Q65384982 P580 "2007-01-01T00:00:00Z" @default.
- Q65384982 P582 "2012-06-01T00:00:00Z" @default.
- Q65384982 P6099 Q42824440 @default.
- Q65384982 P8363 Q78089383 @default.